Study to Assess the Efficacy, Safety, & Tolerability of Valbenazine for

See also
Status	Clinical Trial	Phase
Completed	`NCT03264339` - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy	N/A
Completed	`NCT03902886` - Independent Walking Onset of Children With Cerebral Palsy
Not yet recruiting	`NCT04081675` - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed	`NCT02167022` - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy	N/A
Completed	`NCT04012125` - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy	N/A
Completed	`NCT04489498` - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed	`NCT03677193` - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy	N/A
Completed	`NCT04093180` - Intensive Neurorehabilitation for Cerebral Palsy	N/A
Completed	`NCT02909127` - The Pediatric Eating Assessment Tool
Not yet recruiting	`NCT05024409` - Cerebral Palsy Upper Extremity Orthotic Device	N/A
Not yet recruiting	`NCT03183427` - Corpus Callosum Size in Patients With Pineal Cyst	N/A
Active, not recruiting	`NCT03078621` - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy	Phase 1/Phase 2
Completed	`NCT02849938` - Evaluating the Value of Telehealth for Care of Children With Medical Complexity	N/A
Completed	`NCT02897024` - A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE)	N/A
Not yet recruiting	`NCT02545179` - Web-based Daily Care Training of Children With Cerebral Palsy	N/A
Completed	`NCT02699554` - Quantifying Patient-Specific Changes in Neuromuscular Control in Cerebral Palsy
Completed	`NCT02546999` - Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?	Phase 4
Completed	`NCT02246751` - Case Series_Targeted Training for Trunk Control Cerebral Palsy	N/A
Completed	`NCT01650415` - Erythropoietin Therapy for Children With Cerebral Palsy	Phase 2
Completed	`NCT02400619` - Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT	Phase 1

NCT number	NCT05206513
Study type	Interventional
Source	Neurocrine Biosciences
Contact	Neurocrine Medical Information Call Center
Phone	877-641-3461
Email	[email protected]
Status	Recruiting
Phase	Phase 3
Start date	January 2022
Completion date	August 2024

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms